EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy

Elena Puris iD, Gert Fricker iD, Mikko Gynther iD

Pharmaceutics · 21.01.2023 · 15 (2) · 364

DOI: 10.3390/pharmaceutics15020364 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 21.01.2023. Verfasst von Elena Puris und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmacy and Molecular Biotechnology, Ruprecht-Karls-University, Im Neuenheimer Feld 329, 69120 Heidelberg, Germany. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 335 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transporter-mediated drug resistance is a major obstacle in anticancer drug delivery and a key reason for cancer drug therapy failure. Membrane solute carrier (SLC) transporters play a crucial role in the cellular uptake of drugs. The expression and function of the SLC transporters can be down-regulated in cancer cells, which limits the uptake of drugs into the tumor cells, resulting in the inefficiency of the drug therapy. In this review, we summarize the current understanding of low-SLC-transporter-expression-mediated drug resistance in different types of cancers. Recent advances in SLC-transporter-targeting strategies include the development of transporter-utilizing prodrugs and nanocarriers and the modulation of SLC transporter expression in cancer cells. These strategies will play an important role in the future development of anticancer drug therapies by enabling the efficient delivery of drugs into cancer cells.

Schlagwörter

Stichwörter der Autor:innen

cancerdrug resistancesolute carrier transporters

Autor:innen und Institutionen

  • Institute of Pharmacy and Molecular Biotechnology, Ruprecht-Karls-University, Im Neuenheimer Feld 329, 69120 Heidelberg, Germany.

ORCID-Profile: Elena Puris, Gert Fricker, Mikko Gynther

Zitieren

APA

Puris, E., Fricker, G., & Gynther, M. (2023). The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy. Pharmaceutics, 15(2), 364. https://doi.org/10.3390/pharmaceutics15020364

Vancouver

Puris E, Fricker G, Gynther M. The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy. Pharmaceutics. 2023;15(2):364. doi:10.3390/pharmaceutics15020364

BibTeX
@article{Puris2023,
  author = {Puris, Elena and Fricker, Gert and Gynther, Mikko},
  title = {The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {2},
  pages = {364},
  doi = {10.3390/pharmaceutics15020364}
}
Kostenlos starten →